TerrAscend (TSNDF) Assets Average (2022 - 2026)
TerrAscend (TSNDF) posted quarterly Assets Average of $553.2 million for Q1 2026, down 8.4% year-over-year from $604.0 million in Q1 2025, and down 0.55% quarter-over-quarter from $556.3 million in Q4 2025.
TerrAscend (TSNDF) Assets Average (2022 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Assets Average for 5 consecutive years, with $553.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 8.4% year-over-year to $553.2 million; the TTM figure through Mar 2026 stood at $553.2 million (down 8.4% YoY), while the FY2025 annual figure was $582.3 million, down 8.57% from the prior year.
- Assets Average fell to $553.2 million in Q1 2026 per TSNDF's latest filing, from $556.3 million in the prior quarter.
- Across five years, Assets Average topped out at $1.0 billion in Q2 2022 and bottomed at $350.8 million in Q2 2023.
- Historically, Assets Average has averaged $647.4 million across 5 years, with a median of $657.9 million in 2024.
- Annual changes were most pronounced in 2023 — Assets Average plunged 65.69% — and 2024, when it surged 87.52%.
- TerrAscend's Assets Average stood at $713.5 million in 2022, then fell by 1.81% to $700.6 million in 2023, then retreated by 9.78% to $632.1 million in 2024, then decreased by 11.99% to $556.3 million in 2025, then decreased by 0.55% to $553.2 million in 2026.
- Business Quant data shows TSNDF's Assets Average at $553.2 million in Q1 2026, $556.3 million in Q4 2025, and $563.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | TerrAscend | 187.35 Mn | 145.23 Mn | 36.25 Mn | 551.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 551.40 Mn |
| Mar 31, 2026 | 553.24 Mn |
| Dec 31, 2025 | 556.32 Mn |
| Sep 30, 2025 | 563.63 Mn |
| Jun 30, 2025 | 586.37 Mn |
| Mar 31, 2025 | 603.98 Mn |
| Dec 31, 2024 | 632.08 Mn |
| Sep 30, 2024 | 658.59 Mn |
| Jun 30, 2024 | 657.89 Mn |
| Mar 31, 2024 | 661.03 Mn |
| Dec 31, 2023 | 700.59 Mn |
| Sep 30, 2023 | 367.38 Mn |
| Jun 30, 2023 | 350.83 Mn |
| Mar 31, 2023 | 701.58 Mn |
| Dec 31, 2022 | 713.54 Mn |
| Sep 30, 2022 | 867.05 Mn |
| Jun 30, 2022 | 1.02 Bn |
| Mar 31, 2022 | 809.17 Mn |